{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:35:15Z","timestamp":1760236515135,"version":"build-2065373602"},"reference-count":59,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T00:00:00Z","timestamp":1638144000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Gerencia Regional de Salud (Castilla y Le\u00f3n)","award":["GRS COVID 10\/A\/20"],"award-info":[{"award-number":["GRS COVID 10\/A\/20"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>A high percentage of patients with COVID-19 (coronavirus disease 2019) have previous cardiovascular disease (CVD). The findings presented here came from an epidemiological population-based registry study (real-world data) that enrolled all in-hospital COVID-19 patients with previous CVD from 1 March to 31 May 2020. Death, other comorbidities, hospital stay variables, ventilation type, and main clinical outcomes were evaluated. In Castile and Leon, 35.83% of the 7307 in-hospital COVID-19 patients who participated in this study had previous CVD, particularly arrhythmias (48.97%), cerebrovascular disease (25.02%), ischemic heart disease (22.8%), and chronic heart failure (20.82%). Of the patients, 21.36% were men and more than 90% were over 65 years of age, and the mortality rate achieved 32.93%. The most used medicines were antibiotics (91.41%), antimalarials (73.3%), steroids (46.64%), and antivirals (43.16%). The main predictors of death were age over 65 years (OR: 5), ventilation needs (OR: 2.81), treatment with anti-SIRS (systemic inflammatory response syndrome) medicines (OR: 1.97), antivirals (OR: 1.74) or steroids (OR: 1.68), SIRS (OR: 5.75), SARS (severe acute respiratory syndrome) (OR: 2.44), or AKI (acute kidney injury) (OR: 1.63) occurrence. Chronic heart failure and cerebrovascular disease were associated with a worse clinical course of COVID-19, especially in men older than 65 years with diabetes who developed SIRS, SARS, or AKI.<\/jats:p>","DOI":"10.3390\/jcdd8120167","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T23:22:28Z","timestamp":1638314548000},"page":"167","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Population-Based Registry Analysis on Hospitalized COVID-19 Patients with Previous Cardiovascular Disease: Clinical Profile, Treatment, and Predictors of Death"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2612-934X","authenticated-orcid":false,"given":"Eduardo","family":"Guti\u00e9rrez-Abej\u00f3n","sequence":"first","affiliation":[{"name":"Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"},{"name":"Department of Pharmaceutical Assistance, Castilla y Le\u00f3n Health Council, 47007 Valladolid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (Group CB21\/13\/00051), Carlos III Institute of Health, 28029 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3110-692X","authenticated-orcid":false,"given":"Francisco","family":"Herrera-G\u00f3mez","sequence":"additional","affiliation":[{"name":"Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (Group CB21\/13\/00051), Carlos III Institute of Health, 28029 Madrid, Spain"},{"name":"Transplantation Center, Lausanne University Hospital and University of Lausanne, CH-1011 Lausanne, Switzerland"},{"name":"Department of Kidney Resuscitation and Acute Purification Therapies, Complejo Asistencial de Zamora, 49022 Zamora, Spain"},{"name":"BioCritic, Group for Biomedical Research in Critical Care Medicine, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora","family":"Mart\u00edn-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Hospital Cl\u00ednico Universitario de Valladolid, 47003 Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Tamayo","sequence":"additional","affiliation":[{"name":"BioCritic, Group for Biomedical Research in Critical Care Medicine, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"},{"name":"Department of Anesthesiology, Hospital Cl\u00ednico Universitario de Valladolid, 47003 Valladolid, Spain"},{"name":"Department of Surgery, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-5678","authenticated-orcid":false,"given":"Francisco Javier","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"},{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red de Enfermedades Infecciosas (Group CB21\/13\/00051), Carlos III Institute of Health, 28029 Madrid, Spain"},{"name":"BioCritic, Group for Biomedical Research in Critical Care Medicine, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain"},{"name":"CEIm, Hospital Cl\u00ednico Universitario de Valladolid, 47003 Valladolid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and Impact of Cardiovascular Metabolic Diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin. Res. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11912-020-00945-4","article-title":"The COVID-19 Pandemic and Its Impact on the Cardio-Oncology Population","volume":"22","author":"Asokan","year":"2020","journal-title":"Curr. Oncol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the Cardiovascular System","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and Cardiovascular Disease: From Basic Mechanisms to Clinical Perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ahj.2020.04.025","article-title":"A Current Review of COVID-19 for the Cardiovascular Specialist","volume":"226","author":"Lang","year":"2020","journal-title":"Am. Heart J."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China","volume":"46","author":"Ruan","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/CIRCULATIONAHA.120.047549","article-title":"The Science Underlying COVID-19: Implications for the Cardiovascular System","volume":"142","author":"Liu","year":"2020","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Castagna, F., Kataria, R., Madan, S., Ali, S.Z., Diab, K., Leyton, C., Arfaras-Melainis, A., Kim, P., Giorgi, F.M., and Vukelic, S. (2021). A History of Heart Failure Is an Independent Risk Factor for Death in Patients Admitted with Coronavirus 19 Disease. J. Cardiovasc. Dev. Dis., 8.","DOI":"10.3390\/jcdd8070077"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cjca.2017.12.005","article-title":"Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms","volume":"34","author":"Petrie","year":"2018","journal-title":"Can. J. Cardiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.ajem.2020.04.048","article-title":"Cardiovascular Complications in COVID-19","volume":"38","author":"Long","year":"2020","journal-title":"Am. J. Emerg. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue Distribution of ACE2 Protein, the Functional Receptor for SARS Coronavirus. A First Step in Understanding SARS Pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s11684-020-0754-0","article-title":"Single-Cell RNA-Seq Data Analysis on the Receptor ACE2 Expression Reveals the Potential Risk of Different Human Organs Vulnerable to 2019-NCoV Infection","volume":"14","author":"Zou","year":"2020","journal-title":"Front. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/1074248420967792","article-title":"Hypothesis: Sex-Related Differences in ACE2 Activity May Contribute to Higher Mortality in Men Versus Women With COVID-19","volume":"26","author":"Salah","year":"2021","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nature12711","article-title":"Isolation and Characterization of a Bat SARS-like Coronavirus That Uses the ACE2 Receptor","volume":"503","author":"Ge","year":"2013","journal-title":"Nature"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) as a SARS-CoV-2 Receptor: Molecular Mechanisms and Potential Therapeutic Target","volume":"46","author":"Zhang","year":"2020","journal-title":"Intensive Care Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","article-title":"The Trinity of COVID-19: Immunity, Inflammation and Intervention","volume":"20","author":"Tay","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1161\/01.RES.0000150734.79804.92","article-title":"Cytokine-Induced Modulation of Cardiac Function","volume":"95","author":"Prabhu","year":"2004","journal-title":"Circ. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.CIR.0000131660.51520.9A","article-title":"Bidirectional Relation between Inflammation and Coagulation","volume":"109","author":"Levi","year":"2004","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s11899-020-00567-4","article-title":"The Cardiovascular Complications of Chimeric Antigen Receptor T Cell Therapy","volume":"15","author":"Jamal","year":"2020","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/heartjnl-2020-317056","article-title":"Cardiovascular Manifestations and Treatment Considerations in COVID-19","volume":"106","author":"Kang","year":"2020","journal-title":"Heart"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1093\/eurheartj\/ehaa254","article-title":"Acute Pulmonary Embolism and COVID-19 Pneumonia: A Random Association?","volume":"41","author":"Danzi","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s40265-020-01378-w","article-title":"Remdesivir: First Approval","volume":"80","author":"Lamb","year":"2020","journal-title":"Drugs"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1093\/cvr\/cvaa106","article-title":"COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options","volume":"116","author":"Guzik","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic","volume":"75","author":"Driggin","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","unstructured":"(2021, May 06). Spanish Ministry of Health Clinical Management of COVID-19. Available online: https:\/\/www.mscbs.gob.es\/profesionales\/saludPublica\/ccayes\/alertasActual\/nCov-China\/documentos\/Protocolo_manejo_clinico_ah_COVID-19.pdf."},{"key":"ref_29","unstructured":"(2021, May 06). Spanish Agency for Medicine and Health Products Available Treatments for the Management of Respiratory Infection by SARS-CoV-2. Available online: https:\/\/www.aemps.gob.es\/laAEMPS\/docs\/medicamentos-disponibles-SARS-CoV-2-22-5-2020.pdf?x57200."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Benchimol, E.I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I., S\u00f8rensen, H.T., von Elm, E., Langan, S.M., and RECORD Working Committee (2015). The REporting of Studies Conducted Using Observational Routinely-Collected Health Data (RECORD) Statement. PLoS Med., 12.","DOI":"10.1371\/journal.pmed.1001885"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Guidelines for Reporting Observational Studies","volume":"61","author":"Altman","year":"2008","journal-title":"J. Clin. Epidemiol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Guti\u00e9rrez-Abej\u00f3n, E., Tamayo, E., Mart\u00edn-Garc\u00eda, D., \u00c1lvarez, F.J., and Herrera-G\u00f3mez, F. (2020). Clinical Profile, Treatment and Predictors during the First COVID-19 Wave: A Population-Based Registry Analysis from Castile and Leon Hospitals. Int. J. Environ. Res. Public Health, 17.","DOI":"10.3390\/ijerph17249360"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"657977","DOI":"10.3389\/fmed.2021.657977","article-title":"Clinical Profile, Pharmacological Treatment, and Predictors of Death Among Hospitalized COVID-19 Patients With Acute Kidney Injury: A Population-Based Registry Analysis","volume":"8","author":"Tamayo","year":"2021","journal-title":"Front. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.rce.2020.07.003","article-title":"Clinical Characteristics of Patients Hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry","volume":"220","year":"2020","journal-title":"Rev. Clin. Esp."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.cmi.2020.07.024","article-title":"Characteristics and Predictors of Death among 4035 Consecutively Hospitalized Patients with COVID-19 in Spain","volume":"26","author":"Berenguer","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_36","first-page":"985","article-title":"Risk factors for in-hospital mortality in patients with acute myocardial infarction during the COVID-19 outbreak","volume":"73","author":"Zamorano","year":"2020","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1056\/NEJMoa2005412","article-title":"Epidemiology of COVID-19 in a Long-Term Care Facility in King County, Washington","volume":"382","author":"McMichael","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","article-title":"Clinical Characteristics of Coronavirus Disease 2019 in China","volume":"382","author":"Guan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"m1091","DOI":"10.1136\/bmj.m1091","article-title":"Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study","volume":"368","author":"Chen","year":"2020","journal-title":"BMJ"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"m1985","DOI":"10.1136\/bmj.m1985","article-title":"Features of 20 133 UK Patients in Hospital with COVID-19 Using the ISARIC WHO Clinical Characterisation Protocol: Prospective Observational Cohort Study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ijid.2020.07.076","article-title":"Does Gender Influence Clinical Expression and Disease Outcomes in COVID-19? A Systematic Review and Meta-Analysis","volume":"99","author":"Ortolan","year":"2020","journal-title":"Int. J. Infect. Dis."},{"key":"ref_43","first-page":"100011","article-title":"Sex and Gender Differences in COVID-19: More to Be Learned!","volume":"3","author":"Elgendy","year":"2021","journal-title":"Am. Heart J. Plus"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"020389","DOI":"10.7189\/jogh.10.020389","article-title":"COVID-19: Obesity, Deprivation and Death","volume":"10","author":"Simpson","year":"2020","journal-title":"J. Glob. Health"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1530\/EJE-20-0541","article-title":"How Important Is Obesity as a Risk Factor for Respiratory Failure, Intensive Care Admission and Death in Hospitalised COVID-19 Patients? Results from a Single Italian Centre","volume":"183","author":"Rottoli","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"m1966","DOI":"10.1136\/bmj.m1966","article-title":"Factors Associated with Hospital Admission and Critical Illness among 5279 People with Coronavirus Disease 2019 in New York City: Prospective Cohort Study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_48","first-page":"1775","article-title":"Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy","volume":"323","author":"Onder","year":"2020","journal-title":"JAMA"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Borobia, A.M., Carcas, A.J., Arnalich, F., \u00c1lvarez-Sala, R., Monserrat-Villatoro, J., Quintana, M., Figueira, J.C., Torres Santos-Olmo, R.M., Garc\u00eda-Rodr\u00edguez, J., and Mart\u00edn-Vega, A. (2020). A Cohort of Patients with COVID-19 in a Major Teaching Hospital in Europe. J. Clin. Med., 9.","DOI":"10.3390\/jcm9061733"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/jth.14768","article-title":"Abnormal Coagulation Parameters Are Associated with Poor Prognosis in Patients with Novel Coronavirus Pneumonia","volume":"18","author":"Tang","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"ref_51","first-page":"155","article-title":"Azithromycin, Cardiovascular Risks, QTc Interval Prolongation, Torsade de Pointes, and Regulatory Issues: A Narrative Review Based on the Study of Case Reports","volume":"1","author":"Hancox","year":"2013","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s40264-018-0689-4","article-title":"Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature","volume":"41","author":"Chatre","year":"2018","journal-title":"Drug Saf."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and Biochemical Indexes from 2019-NCoV Infected Patients Linked to Viral Loads and Lung Injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Stockman, L.J., Bellamy, R., and Garner, P. (2006). SARS: Systematic Review of Treatment Effects. PLoS Med., 3.","DOI":"10.1371\/journal.pmed.0030343"},{"key":"ref_56","unstructured":"(2020, April 10). KALETRA(R) Oral Film Coated Tablets, Oral Solution, Lopinavir Ritonavir Oral Film Coated Tablets, Oral Solution. Product Insert. North Chicago, IL: AbbVie Inc. (per FDA). Available online: https:\/\/books.google.com.cu\/books?hl=es&lr=&id=ETv2DQAAQBAJ&oi=fnd&pg=PA75&dq=KALETRA(R)+oral+film+coated+tablets,+oral+solution,+lopinavir+ritonavir+oral+film+coated+tablets,+oral+solution.+Product+Insert.+AbbVie+Inc.+(per+FDA),+North+Chicago,+IL,+2013.+66.+34.+&ots=A4xd8b9QG9&sig=yPH3vqbA74Tv69vJ7GjsiDj8CIo&redir_esc=y#v=onepage&q&f=false."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/art.41095","article-title":"Cardiovascular Safety of Tocilizumab Versus Etanercept in Rheumatoid Arthritis: A Randomized Controlled Trial","volume":"72","author":"Giles","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"106883","DOI":"10.1016\/j.vph.2021.106883","article-title":"Thromboprophylaxis Strategies to Improve the Prognosis of COVID-19","volume":"139","author":"Bertoletti","year":"2021","journal-title":"Vascul. Pharmacol."},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"ATTACC Investigators, ACTIV-4a Investigators, REMAP-CAP Investigators, Lawler, P.R., Goligher, E.C., Berger, J.S., Neal, M.D., McVerry, B.J., Nicolau, J.C., and Gong, M.N. (2021). Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with COVID-19. N. Engl. J. Med., 385, 790\u2013802.","DOI":"10.1056\/NEJMoa2105911"}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/8\/12\/167\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:37:08Z","timestamp":1760168228000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/8\/12\/167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,29]]},"references-count":59,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["jcdd8120167"],"URL":"https:\/\/doi.org\/10.3390\/jcdd8120167","relation":{},"ISSN":["2308-3425"],"issn-type":[{"type":"electronic","value":"2308-3425"}],"subject":[],"published":{"date-parts":[[2021,11,29]]}}}